regorafenib - stivarga ®
Published 6 years ago • 1.5K plays • Length 9:04Download video MP4
Download video MP3
Similar videos
-
2:06
stivarga (regorafenib)- metastatic colorectal cancer
-
1:09
survival benefit confirmed in real-life analysis of second-line regorafenib in hcc
-
4:14
the use of regorafenib in clinical practice
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
3:14
when you have decided to prescribe regorafenib
-
2:52
refine: a real-world analysis of regorafenib in patients with unresectable hcc
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
4:10
lenz: stivarga (regorafenib) treatment, dosing strategies
-
0:49
dr. bendell on remaining questions with regorafenib in hcc
-
7:46
clinical use of regorafenib in mhcc
-
2:58
treatment response and side effects with regorafenib
-
1:20
dosing of stivarga
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
1:47
dr. jordi bruix on the impact regorafenib will have on liver cancer treatment
-
1:04
exploring regorafenib and nivolumab as treatment for colorectal cancer
-
0:56
philip philip, md on stivarga (regorafenib) dosage in 2nd line treatment of mcrc
-
0:58
managing colorectal cancer in patients who progress on regorafenib
-
0:57
choosing between tas-102 and regorafenib in colorectal cancer
-
1:47
alan venook, md relays the optimal dose for regorafenib (stivarga) in the 2nd line treatment of mcrc